Trial intelligence / Profile preview

Chlorhexidine vs Povidone-iodine Vaginal Scrub for C-Section

NCT03925155Phase 3Withdrawn

Sponsor
Montefiore Medical Center
Start
May 2020
Primary completion
May 2022
Modality
Small Molecules
01

Overview

Phase 3, randomised, single-blind trial of chlorhexidine in postpartum endometritis and surgical site infection (SSI) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Postpartum Endometritis at 30 days. Planned start May 2020; status: withdrawn.

02

Drugs

chlorhexidine
03

Conditions

postpartum endometritissurgical site infection (SSI)

Beyond the preview

Go deeper on NCT03925155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03925155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call